ACG
PFE icon

Allen Capital Group’s Pfizer PFE Stock Holding History

Allen Capital Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.94M Buy
211,583
+15,347
+8% +$409K 0.53% 47
2025
Q4 		$4.89M Buy
196,236
+9,688
+5% +$244K 0.45% 53
2025
Q3 		$4.75M Buy
186,548
+17,363
+10% +$429K 0.45% 55
2025
Q2 		$4.1M Buy
169,185
+26,149
+18% +$610K 0.42% 58
2025
Q1 		$3.62M Buy
143,036
+17,454
+14% +$457K 0.41% 59
2024
Q4 		$3.33M Buy
125,582
+11,661
+10% +$316K 0.4% 55
2024
Q3 		$3.3M Buy
113,921
+9,546
+9% +$278K 0.41% 55
2024
Q2 		$2.92M Buy
104,375
+586
+0.6% +$16.1K 0.4% 58
2024
Q1 		$2.88M Sell
103,789
-3,969
-4% -$110K 0.41% 55
2023
Q4 		$3.1M Buy
107,758
+40,145
+59% +$1.21M 0.49% 45
2023
Q3 		$2.29M Buy
67,613
+2,026
+3% +$71.6K 0.41% 55
2023
Q2 		$2.41M Buy
65,587
+4,164
+7% +$162K 0.41% 55
2023
Q1 		$2.51M Buy
+61,423
New +$2.65M 0.46% 53
2022
Q4 		– Sell
-43,825
Closed -$1.92M – 120
2022
Q3 		$1.92M Buy
43,825
+2,086
+5% +$101K 0.44% 51
2022
Q2 		$2.19M Buy
41,739
+795
+2% +$40.5K 0.44% 47
2022
Q1 		$2.12M Buy
40,944
+1,351
+3% +$70.1K 0.4% 55
2021
Q4 		$2.34M Buy
39,593
+172
+0.4% +$8.52K 0.38% 53
2021
Q3 		$1.7M Buy
39,421
+1,064
+3% +$47.1K 0.34% 63
2021
Q2 		$1.5M Buy
38,357
+9,974
+35% +$388K 0.3% 66
2021
Q1 		$1.03M Buy
28,383
+6,424
+29% +$228K 0.23% 78
2020
Q4 		$808K Buy
21,959
+857
+4% +$31.4K 0.19% 81
2020
Q3 		$739K Sell
21,102
-128
-0.6% -$4.49K 0.19% 80
2020
Q2 		$659K Buy
+21,230
New +$721K 0.17% 80
2019
Q1 		– Sell
-10,766
Closed -$434K – 122
2018
Q4 		$434K Buy
10,766
+3,294
+44% +$137K 0.15% 89
2018
Q3 		$312K Buy
7,472
+930
+14% +$35.8K 0.1% 104
2018
Q2 		$225K Sell
6,542
-2,186
-25% -$74.7K 0.08% 112
2018
Q1 		$294K Buy
+8,728
New +$300K 0.11% 99

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Allen Capital Group's PFE Position: Q1 2026 in Review

Allen Capital Group increased its Pfizer (PFE) stake by 7.8% in Q1 2026, buying an estimated $409K and bringing the position to 211,583 shares worth $5.94M. The position accounts for 0.53% of the portfolio, ranked #47.

Allen Capital Group first reported a position in PFE in Q1 2018 and has held it in 27 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Allen Capital Group held 211,583 shares of Pfizer worth $5.94M as of Q1 2026.
  • Allen Capital Group bought 15,347 Pfizer shares in Q1 2026, an estimated $409K.
  • Pfizer made up 0.53% of Allen Capital Group's portfolio in Q1 2026, its #47 holding.
  • Allen Capital Group first reported a position in Pfizer in Q1 2018 and has held it in 27 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Allen Capital Group's 13F filing for Q1 2026, filed 27 May 2026.